Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
4
×
detroit top stories
fda
4
×
glaxosmithkline
4
×
indiana blog main
indiana top stories
life sciences
medical devices
4
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
clinical trials
gene therapy
ipo
novartis
akcea therapeutics
allergan
anemia
biofourmis
biogen
What
bio
roundup
cancer
days
therapeutics
abbvie’s
ahead
allogene
august
biofourmis
biotech
black
bucks
busy
celebrate
chance
companies
continue
corner
crispr
day
debut
decisions
devices
diamond
diamond’s
diversity
drugs
fda
forward
holiday
hot
immunotherapy
indication
investors
ipo
juno
labor
leading
legacy
Language
unset
Current search:
fda
×
biotech
×
" detroit blog main "
×
glaxosmithkline
×
" medical devices "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More